Projects

Identification and evaluation of prognostic markers involving Rho/ROCK signaling pathway in radiation response in cervical cancer.

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2018 - 2022

Project Lead

Sweta Srivastava

Authors

Sweta Srivastava, Avinash H Udayashankara

Project Status

completed

Project Type

Prospective (Funded by RGUHS)